Taming “The Monster” – with Koen Sandra - Scorecard - MDSpire

Taming “The Monster” – with Koen Sandra

  • June 9, 2026

  • 11 min

Share

Clinical Scorecard: Taming “The Monster” – with Koen Sandra

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationAnalytical scientists and biopharmaceutical researchers focusing on complex therapeutics.
Care Setting

Key Highlights

  • Focus on complex biotherapeutics including antibody-oligonucleotide conjugates and their analytical challenges.

Guideline-Based Recommendations

Diagnosis

  • Consider molecular characterization techniques for accurate diagnosis.

Management

  • Implement integrated analytical workflows for managing complex biotherapeutics.

Monitoring & Follow-up

  • Regularly assess the stability and efficacy of biopharmaceuticals using advanced analytics.

Risks

  • Identify potential analytical pitfalls in characterizing novel biotherapeutics.

Patient & Prescribing Data

Patients receiving biopharmaceutical therapies requiring complex analytical characterization.

Clinical Best Practices

  • Utilize orthogonal, high-resolution analytics for complex molecules, such as LC-MS and NMR.
  • Consolidate multiple assays into single platforms for efficiency, improving throughput and reducing costs.
  • Engage in continuous knowledge sharing and collaboration among scientists to foster innovation.

Related Resources & Content

    Original Source(s)

    Related Content